Literature DB >> 5497834

The release of biologically active substances from isolated lungs by 5-hydroxytryptamine and tryptamine.

V A Alabaster, Y S Bakhle.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 5497834      PMCID： PMC1703107     

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN： 0007-1188            Impact factor:   8.739


× No keyword cloud information.
  7 in total

1.  Slow reacting substance and related compounds.

Authors:  W E BROCKLEHURST
Journal:  Prog Allergy       Date:  1962

2.  5-Hydroxytryptamine; pharmacological action and destruction in perfused lungs.

Authors:  J H GADDUM; C O HEBB; A SILVER; A A SWAN
Journal:  Q J Exp Physiol Cogn Med Sci       Date:  1953

3.  The effect of a serotonin antagonist (UML 491) in carcinoid disease.

Authors:  W S PEART; J I ROBERTSON
Journal:  Lancet       Date:  1961-11-25       Impact factor: 79.321

4.  Release of additional factors in anaphylaxis and its antagonism by anti-inflammatory drugs.

Authors:  P J Piper; J R Vane
Journal:  Nature       Date:  1969-07-05       Impact factor: 49.962

Review 5.  The release and fate of vaso-active hormones in the circulation.

Authors:  J R Vane
Journal:  Br J Pharmacol       Date:  1969-02       Impact factor: 8.739

6.  Removal of 5-hydroxytryptamine by rat isolated lung.

Authors:  V A Alabaster; Y S Bakhle
Journal:  Br J Pharmacol       Date:  1970-02       Impact factor: 8.739

7.  5-hydroxytryptamine in the circulation of the dog.

Authors:  D P Thomas; J R Vane
Journal:  Nature       Date:  1967-10-28       Impact factor: 49.962
  7 in total
  9 in total

Review 1.  Aspects of release of pharmacologically active substances from the lungs by chemical stimuli.

Authors:  B B Vargaftig
Journal:  Agents Actions       Date:  1976-07

2.  Tryptamine receptors in rat pulmonary artery.

Authors:  Y S Bakhle; T W Smith
Journal:  Br J Pharmacol       Date:  1974-07       Impact factor: 8.739

3.  Proceedings: The nature of the tryptamine receptor mediating spasmogen release from rat isolated lungs.

Authors:  Y S Bakhle; T W Smith
Journal:  Br J Pharmacol       Date:  1974-03       Impact factor: 8.739

4.  Release of spasmogenic substances induced by vasoactive amines from isolated lungs.

Authors:  Y S Bakhle; T W Smith
Journal:  Br J Pharmacol       Date:  1972-11       Impact factor: 8.739

Review 5.  Auto-modulation of release of pharmacological mediators of immediate (type I) hypersensitivity. A review.

Authors:  M C Holroyde; J F Burka; P Eyre
Journal:  Agents Actions       Date:  1977-10

6.  Prostaglandin release in canine acute haemorrhagic pancreatitis.

Authors:  G Glazer; A Bennett
Journal:  Gut       Date:  1976-01       Impact factor: 23.059

7.  Phospholipase A2 activity of guinea-pig isolated perfused lungs: stimulation, and inhibition by anti-inflammatory steroids.

Authors:  G J Blackwell; R J Flower; F P Nijkamp; J R Vane
Journal:  Br J Pharmacol       Date:  1978-01       Impact factor: 8.739

8.  Bronchial hyperreactivity to prostaglandin F 2 and histamine in patients with asthma.

Authors:  A A Mathé; P Hedqvist; A Holmgren; N Svanborg
Journal:  Br Med J       Date:  1973-01-27

9.  Relaxant response of goat trachea to 5-hydroxy-tryptamine mediated by D-tryptamine receptors.

Authors:  N Chand; L DeRoth; P Eyre
Journal:  Br J Pharmacol       Date:  1979-06       Impact factor: 8.739
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.